NORTHERN IRELAND
Northern Ireland: Driving the Future of Healthcare & Life Sciences
Attributed to Swathi Sri, Head of Territory – India, Middle East, Africa, at Invest Northern Ireland
Northern Ireland has positioned itself as an exceptional place for life and health sciences businesses. It boasts a skilled and solutions- focused workforce, top-tier research facilities, and strong connections between industry, academia, and clinicians. The region stands out in the UK and around the world as a hub for developing and commercialising cutting-edge research. An additional edge being that Northern Ireland is the only location in the world that provides tariff-free access to both GB and EU markets. This unique regulatory environment makes it an ideal place for medical device and diagnostic manufacturers to cater to both markets.
implementation of diagnostic results, applications, and treatment research. Northern Ireland’s medtech industry,
Swathi Sri
rooted in a rich legacy, is strengthened by the strong support from the government, academic institutions, and a mix of innovative local and global companies. The
Innovation Success in Northern Ireland’s life and health sciences sector has been propelled by innovation. Its uniquely integrated ecosystem fosters seamless connections between scientific research and clinical outcomes, accelerating every phase of the development life cycle and enabling faster commercialisation and
region’s strong academic, research, and innovation landscape is significantly influenced by prestigious universities like Queen’s University Belfast and Ulster University, along with 18 centres of excellence in life and health sciences. These form a solid foundation for future growth, instilling confidence in the industry’s potential. It is home to over a thousand researchers specialising in a wide array of fields, such as cancer research, nanotechnology, biomedical science, health innovation, and experimental medicine. The close collaboration between universities and the health- tech industry has given rise to numerous thriving companies that originally emerged as academic spinouts. This clearly showcases the region’s immense potential for progress and ground-breaking innovation. Northern Ireland’s potential as a valuable
Queen’s University Belfast DUB AI 2025
asset to the UK Life and Health Science Cluster is tremendous. The region’s innovative contributions in fields such as diagnostics, data harmonisation, digital healthcare, wearable tech, and advanced drug delivery systems are shaping the future of the industry. With a thriving ecosystem of over 250 enterprises, including both local stalwarts like Almac
UKHEALTHCARE P A VILION. COM 9
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
